Knight Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	108.05	76.45	80.11	58.76	71.68	85.96
Short-Term Investments	19.24	18.83	62.23	95.66	85.83	63.54
Cash & Short-Term Investments	127.29	95.28	142.33	154.42	157.51	149.5
Cash Growth	-10.05%	-33.05%	-7.83%	-1.96%	5.35%	-60.34%
Accounts Receivable	141.4	127.78	105.2	88.72	94.89	55.39
Other Receivables	10.02	6.06	4.34	7.43	11.29	5.06
Total Trade Receivables	151.42	133.84	109.54	96.15	106.18	60.44
Inventory	141.92	135.87	102.7	91.83	92.49	72.4
Other Current Assets	26.32	29.85	42.25	22.71	39.45	22.63
Total Current Assets	446.95	394.84	396.81	365.12	395.62	304.97
Net Property, Plant & Equipment	30.37	21.93	20.02	17.86	22.63	31.39
Other Intangible Assets	354.04	379.51	283.61	289.96	338.78	350.3
Goodwill	95.31	89.98	86.48	79.84	82.27	75.4
Long-Term Investments	78.83	79.48	103.43	120.02	158.02	178.95
Other Long-Term Assets	81.11	80.56	73.45	72.69	57.51	50.88
Total Assets	1,087	1,046	963.8	945.49	1,055	991.89
Accounts Payable	147.33	120.87	78.35	85.37	106.06	65.31
Short-Term Debt	17.91	16.73	17.49	17.85	17.67	26.66
Current Portion of Leases	3.7	3.4	2.64	1.73	2.58	1.61
Other Current Liabilities	23.51	24.26	12.78	9.09	15.01	11.72
Total Current Liabilities	192.45	165.26	111.25	114.03	141.32	105.3
Long-Term Debt	40.73	51.17	25.9	44.02	52.4	9.27
Long-Term Leases	7.44	6.62	3.43	5.5	5.05	3.42
Other Long-Term Liabilities	58.71	55.99	28.11	35.08	30.21	31.89
Total Long-Term Liabilities	106.88	113.77	57.44	84.59	87.66	44.57
Total Liabilities	299.33	279.03	168.69	198.62	228.98	149.87
Common Stock	525.53	530.14	534.27	540.05	599.06	628.85
Additional Paid-in Capital	30.65	32.45	25.83	26.11	23.78	21.89
Accumulated Other Comprehensive Income	70.25	55.74	80.22	29.83	41.27	-0.38
Retained Earnings	160.84	148.94	154.79	150.89	161.76	191.65
Shareholders' Equity	787.27	767.27	795.11	746.87	825.86	842.02
Total Liabilities & Equity	1,087	1,046	963.8	945.49	1,055	991.89
Total Debt	69.78	77.91	49.46	69.09	77.7	40.96
Net Cash (Debt)	57.52	17.37	92.87	85.33	79.81	108.54
Net Cash Growth	231.08%	-81.30%	8.84%	6.92%	-26.48%	-66.16%
Net Cash Per Share	0.58	0.17	0.92	0.79	0.69	0.87
Book Value	787.27	767.27	795.11	746.87	825.86	842.02
Book Value Per Share	7.91	7.71	7.84	6.95	7.19	6.76
Tangible Book Value	337.93	297.78	425.02	377.07	404.8	416.32
Tangible Book Value Per Share	3.40	2.99	4.19	3.51	3.52	3.34

Updated May 7, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.